These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23242672)

  • 21. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive cells and tumour microenvironment: focus on mesenchymal stem cells and myeloid derived suppressor cells.
    Bianchi G; Borgonovo G; Pistoia V; Raffaghello L
    Histol Histopathol; 2011 Jul; 26(7):941-51. PubMed ID: 21630223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. STAT3 Silencing and TLR7/8 Pathway Activation Repolarize and Suppress Myeloid-Derived Suppressor Cells From Breast Cancer Patients.
    Safarzadeh E; Mohammadi A; Mansoori B; Duijf PHG; Hashemzadeh S; Khaze V; Kazemi T; Derakhshani A; Silvestris N; Baradaran B
    Front Immunol; 2020; 11():613215. PubMed ID: 33679700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
    Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
    Front Immunol; 2020; 11():585214. PubMed ID: 33613512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma.
    Yu SJ; Ma C; Heinrich B; Brown ZJ; Sandhu M; Zhang Q; Fu Q; Agdashian D; Rosato U; Korangy F; Greten TF
    J Hepatol; 2019 Mar; 70(3):449-457. PubMed ID: 30414862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid derived suppressor cells-An overview of combat strategies to increase immunotherapy efficacy.
    Draghiciu O; Lubbers J; Nijman HW; Daemen T
    Oncoimmunology; 2015 Jan; 4(1):e954829. PubMed ID: 25949858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppression of T cells by myeloid-derived suppressor cells in cancer.
    Chen J; Ye Y; Liu P; Yu W; Wei F; Li H; Yu J
    Hum Immunol; 2017 Feb; 78(2):113-119. PubMed ID: 27939507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon regulatory factor 4 (IRF4) controls myeloid-derived suppressor cell (MDSC) differentiation and function.
    Nam S; Kang K; Cha JS; Kim JW; Lee HG; Kim Y; Yang Y; Lee MS; Lim JS
    J Leukoc Biol; 2016 Dec; 100(6):1273-1284. PubMed ID: 27601624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid-Derived Suppressor Cells in
    Fresno M; Gironès N
    Front Cell Infect Microbiol; 2021; 11():737364. PubMed ID: 34513737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel adherent CD11b
    Tsubaki T; Kadonosono T; Sakurai S; Shiozawa T; Goto T; Sakai S; Kuchimaru T; Sakamoto T; Watanabe H; Kondoh G; Kizaka-Kondoh S
    Oncotarget; 2018 Feb; 9(13):11209-11226. PubMed ID: 29541408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Understanding the Differentiation, Expansion, Recruitment and Suppressive Activities of Myeloid-Derived Suppressor Cells in Cancers.
    Lim HX; Kim TS; Poh CL
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis.
    Qin G; Lian J; Huang L; Zhao Q; Liu S; Zhang Z; Chen X; Yue D; Li L; Li F; Wang L; Umansky V; Zhang B; Yang S; Zhang Y
    Oncoimmunology; 2018; 7(7):e1442167. PubMed ID: 29900050
    [No Abstract]   [Full Text] [Related]  

  • 34. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
    Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives.
    Safari E; Ghorghanlu S; Ahmadi-Khiavi H; Mehranfar S; Rezaei R; Motallebnezhad M
    J Cell Physiol; 2019 Jul; 234(7):9966-9981. PubMed ID: 30537008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vasoactive intestinal peptide induces CD14+HLA-DR‑/low myeloid-derived suppressor cells in gastric cancer.
    Li G; Wu K; Tao K; Lu X; Ma J; Mao Z; Li H; Shi L; Li J; Niu Y; Xiang F; Wang G
    Mol Med Rep; 2015 Jul; 12(1):760-8. PubMed ID: 25695487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interleukin 33 in tumor microenvironment is crucial for the accumulation and function of myeloid-derived suppressor cells.
    Xiao P; Wan X; Cui B; Liu Y; Qiu C; Rong J; Zheng M; Song Y; Chen L; He J; Tan Q; Wang X; Shao X; Liu Y; Cao X; Wang Q
    Oncoimmunology; 2016; 5(1):e1063772. PubMed ID: 26942079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma.
    Wang Y; Sun H; Zhu N; Wu X; Sui Z; Gong L; Yu Z
    Front Oncol; 2021; 11():640080. PubMed ID: 33854974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myeloid-derived suppressor cells in cancer immunotherapy-clinical perspectives.
    Mortezaee K
    Life Sci; 2021 Jul; 277():119627. PubMed ID: 34004256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma.
    Weber R; Riester Z; Hüser L; Sticht C; Siebenmorgen A; Groth C; Hu X; Altevogt P; Utikal JS; Umansky V
    J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32788238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.